Metastasis Directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-Resistant Prostate Cancer

被引：0

作者：

Deek, M. P. ^{[1
]}

Taparra, K. ^{[2
]}

Phillips, R. ^{[1
]}

Velho, P. Isaacsson ^{[1
]}

Gao, R. W. ^{[3
]}

Deville, C., Jr. ^{[1
]}

Song, D. ^{[4
]}

Greco, S. C. ^{[4
]}

Carducci, M. ^{[1
]}

Eisenberger, M. ^{[1
]}

DeWeese, T. L. ^{[4
]}

Denmeade, S. ^{[1
]}

Pienta, K. ^{[5
]}

Paller, C. ^{[1
]}

Antonarakis, E. S. ^{[1
]}

Olivier, K. ^{[6
]}

Park, S. S. ^{[6
]}

Tran, P. T. ^{[4
]}

Stish, B. J. ^{[6
]}

机构：

[1] Johns Hopkins Med, Baltimore, MD USA

[2] Mayo Clin, Alix Sch Med, Rochester, MN USA

[3] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA

[4] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD USA

[5] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Med Oncol, Baltimore, MD USA

[6] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 108卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4079

引用

页码：E893 / E894

页数：2

共 50 条

[21] Evolving Personalized Therapy for Castration-Resistant Prostate Cancer
Liu, Hsin-Ho
Tsai, Yuh-Shyan
Lai, Chen-Li
Tang, Chih-Hsin
Lai, Chih-Ho
Wu, Hsi-Chin
Hsieh, Jer-Tsong
Yang, Che-Rei
BIOMEDICINE-TAIWAN, 2014, 4 (01): : 7 - 15
[22] Targeted Therapy in the Treatment of Castration-Resistant Prostate Cancer
Derleth, Christina L.
Yu, Evan Y.
ONCOLOGY-NEW YORK, 2013, 27 (07): : 620 - 628
[23] Novel hormonal therapy for castration-resistant prostate cancer
Sternberg, C. N.
ANNALS OF ONCOLOGY, 2012, 23 : 259 - 263
[24] Therapy selection for metastasized castration-resistant prostate cancer
von Amsberg, G.
Steuber, T.
Lorch, A.
ONKOLOGE, 2015, 21 (09): : 825 - +
[25] Has the Time Arrived for Biomarker-Directed Therapy in Castration-Resistant Prostate Cancer?
Taplin, Mary-Ellen
Balk, Steven P.
JAMA ONCOLOGY, 2015, 1 (05) : 577 - 579
[26] TREATMENT OUTCOMES OF PROGRESSIVE SITE-DIRECTED THERAPY FOR OLIGO-PROGRESSIVE CASTRATION-RESISTANT PROSTATE CANCER
Yoshida, Soichiro
Takahara, Taro
Arita, Yuki
Ishii, Chikako
Toda, Kazuma
Sakamoto, Tsuyoshi
Kijima, Toshiki
Yokoyama, Minato
Ishioka, Junichiro
Matsuoka, Yoh
Saito, Kazutaka
Yoshimura, Ryoichi
Fujii, Yasuhisa
JOURNAL OF UROLOGY, 2020, 203 : E565 - E565
[27] CLINICAL EFFICACY, FEASIBILITY, AND PROGNOSTIC FACTORS FOR SEQUENTIAL DOCETAXEL THERAPY IN THE PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER
Tanaka, Hajime
Yuasa, Takeshi
Ito, Masaya
Saito, Kazutaka
Sakura, Mizuaki
Kitsukawa, Shinichi
Urakami, Shinji
Yamamoto, Shinya
Masuda, Hitoshi
Fukui, Iwao
Yonese, Junji
JOURNAL OF UROLOGY, 2013, 189 (04): : E392 - E392
[28] Feasibility and efficacy of sequential systemic therapy for metastatic castration-resistant prostate cancer in a rural health care setting
Nieder, Carsten
Dalhaug, Astrid
Haukland, Ellinor
SCANDINAVIAN JOURNAL OF UROLOGY, 2020, 54 (02) : 110 - 114
[29] The role of prostate-specific antigen changes in predicting overall survival after progressive-site directed therapy for oligoprogressive castration-resistant prostate cancer
Yoshida, Soichiro
Takahara, Taro
Tanaka, Hajime
Yokoyama, Minato
Yoshimura, Ryoichi
Fujii, Yasuhisa
INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (07) : 616 - 617
[30] Prostate-Specific Membrane Antigen-Directed Therapy for Metastatic Castration-Resistant Prostate Cancer
Teo, Min Yuen
Morris, Michael J.
CANCER JOURNAL, 2016, 22 (05): : 347 - 352

← 1 2 3 4 5 →